Lluı́s Raich

1.5k total citations
22 papers, 670 citations indexed

About

Lluı́s Raich is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Lluı́s Raich has authored 22 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Organic Chemistry and 6 papers in Infectious Diseases. Recurrent topics in Lluı́s Raich's work include Carbohydrate Chemistry and Synthesis (15 papers), Glycosylation and Glycoproteins Research (7 papers) and Enzyme Production and Characterization (6 papers). Lluı́s Raich is often cited by papers focused on Carbohydrate Chemistry and Synthesis (15 papers), Glycosylation and Glycoproteins Research (7 papers) and Enzyme Production and Characterization (6 papers). Lluı́s Raich collaborates with scholars based in Spain, United Kingdom and United States. Lluı́s Raich's co-authors include Carme Rovira, Albert Ardèvol, Frank Noé, Javier Iglesias‐Fernández, G.J. Davies, Andrea M. Klingler, Nurit P. Azouz, Marc E. Rothenberg, Simon Olsson and Tim Hempel and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Lluı́s Raich

21 papers receiving 664 citations

Peers

Lluı́s Raich
Lluı́s Raich
Citations per year, relative to Lluı́s Raich Lluı́s Raich (= 1×) peers Stanislav Kozmon

Countries citing papers authored by Lluı́s Raich

Since Specialization
Citations

This map shows the geographic impact of Lluı́s Raich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluı́s Raich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluı́s Raich more than expected).

Fields of papers citing papers by Lluı́s Raich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluı́s Raich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluı́s Raich. The network helps show where Lluı́s Raich may publish in the future.

Co-authorship network of co-authors of Lluı́s Raich

This figure shows the co-authorship network connecting the top 25 collaborators of Lluı́s Raich. A scholar is included among the top collaborators of Lluı́s Raich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluı́s Raich. Lluı́s Raich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hempel, Tim, Jonathan H. Shrimp, Nina Moor, et al.. (2025). Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor. Nature Communications. 16(1). 6949–6949.
2.
Raich, Lluı́s, Katharina Meier, Judith Günther, et al.. (2021). Discovery of a hidden transient state in all bromodomain families. Proceedings of the National Academy of Sciences. 118(4). 20 indexed citations
3.
Azouz, Nurit P., Andrea M. Klingler, Victoria Callahan, et al.. (2021). Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2–Priming Protease TMPRSS2. SHILAP Revista de lepidopterología. 6(1). 55–74. 68 indexed citations
4.
Hempel, Tim, Nadine Krüger, Lluı́s Raich, et al.. (2021). Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties. Chemical Science. 12(38). 12600–12609. 15 indexed citations
5.
Sobala, L.F., Gaetano Speciale, Sha Zhu, et al.. (2020). An Epoxide Intermediate in Glycosidase Catalysis. ACS Central Science. 6(5). 760–770. 40 indexed citations
6.
Hempel, Tim, Lluı́s Raich, Simon Olsson, et al.. (2020). Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat. Chemical Science. 12(3). 983–992. 76 indexed citations
7.
Tezé, David, et al.. (2020). A Single Point Mutation Converts GH84 O-GlcNAc Hydrolases into Phosphorylases: Experimental and Theoretical Evidence. Journal of the American Chemical Society. 142(5). 2120–2124. 30 indexed citations
8.
Artola, Marta, Lluı́s Raich, Liang Wu, et al.. (2019). α-d-Gal-cyclophellitol cyclosulfamidate is a Michaelis complex analog that stabilizes therapeutic lysosomal α-galactosidase A in Fabry disease. Chemical Science. 10(40). 9233–9243. 11 indexed citations
9.
Raich, Lluı́s, et al.. (2019). Modeling catalytic reaction mechanisms in glycoside hydrolases. Current Opinion in Chemical Biology. 53. 183–191. 32 indexed citations
10.
Bailey, H., Lluı́s Raich, Javier Iglesias‐Fernández, et al.. (2018). Palladium-mediated enzyme activation suggests multiphase initiation of glycogenesis. Nature. 563(7730). 235–240. 47 indexed citations
11.
Rivas, Matilde de las, Helena Coelho, Erandi Lira‐Navarrete, et al.. (2018). Structural and Mechanistic Insights into the Catalytic-Domain-Mediated Short-Range Glycosylation Preferences of GalNAc-T4. ACS Central Science. 4(9). 1274–1290. 39 indexed citations
12.
Raich, Lluı́s, et al.. (2017). Conformational Analysis of the Mannosidase Inhibitor Kifunensine: A Quantum Mechanical and Structural Approach. ChemBioChem. 18(15). 1496–1501. 14 indexed citations
13.
Wander, Dennis P. A., Wendy A. Offen, Marta Artola, et al.. (2017). Carba-cyclophellitols Are Neutral Retaining-Glucosidase Inhibitors. Journal of the American Chemical Society. 139(19). 6534–6537. 23 indexed citations
14.
Artola, Marta, Liang Wu, María Pía Ferraz, et al.. (2017). 1,6-Cyclophellitol Cyclosulfates: A New Class of Irreversible Glycosidase Inhibitor. ACS Central Science. 3(7). 784–793. 45 indexed citations
15.
Raich, Lluı́s, et al.. (2017). The molecular mechanism of the ligand exchange reaction of an antibody against a glutathione-coated gold cluster. Nanoscale. 9(9). 3121–3127. 17 indexed citations
16.
Raich, Lluı́s, D. Albesa-Jové, Beatriz Trastoy, et al.. (2017). The Molecular Mechanism of Substrate Recognition and Catalysis of the Membrane Acyltransferase PatA from Mycobacteria. ACS Chemical Biology. 13(1). 131–140. 11 indexed citations
17.
Raich, Lluı́s, Alba Nin‐Hill, Albert Ardèvol, & Carme Rovira. (2016). Enzymatic Cleavage of Glycosidic Bonds. Methods in enzymology on CD-ROM/Methods in enzymology. 577. 159–183. 31 indexed citations
18.
Jin, Yi, Alan John, Lluı́s Raich, et al.. (2016). A β-Mannanase with a Lysozyme-like Fold and a Novel Molecular Catalytic Mechanism. ACS Central Science. 2(12). 896–903. 40 indexed citations
19.
Sobala, L.F., Lluı́s Raich, Andrew J. Thompson, et al.. (2016). Contribution of Shape and Charge to the Inhibition of a Family GH99 endo-α-1,2-Mannanase. Journal of the American Chemical Society. 139(3). 1089–1097. 15 indexed citations
20.
Raich, Lluı́s, Vladimir S. Borodkin, Wenxia Fang, et al.. (2016). A Trapped Covalent Intermediate of a Glycoside Hydrolase on the Pathway to Transglycosylation. Insights from Experiments and Quantum Mechanics/Molecular Mechanics Simulations. Journal of the American Chemical Society. 138(10). 3325–3332. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026